摘要
背景:维生素D(VD)和白藜芦醇(RSV)是两种营养分子,报道有神经保护作用,并从细胞模型的研究结果表明,白藜芦醇能增强维生素D的作用。快速老化小鼠容易发生8(SAMP8)是阿尔茨海默病(AD)的有用模型相关的记忆障碍。 目的:我们的目的是探讨白藜芦醇维生素D的结合会影响记忆障碍的SAMP8小鼠,以及潜在的机制。 方法:SAMP8小鼠及其控制加速衰老小鼠抗1(SAMR1)小鼠(10周龄)随机分为5组,即正常对照组、模型组、SAMP8小鼠补充VD组、SAMP8小鼠补充RSV组和SAMP8小鼠辅以VD和RSV组。干预结束时,morris水迷宫(MWM)测试是用来评估认知功能。解剖海马和顶叶皮质作进一步分析。 结果:VD和RSV结合显着增加的时间花在目标象限和一些交叉通过Morris水迷宫试验。在海马,联合干预显著降低可溶性β42水平,BACE1蛋白的表达。在皮层,联合治疗显著降低tau蛋白在serine404和p-p53的磷酸化,以及增强CREB蛋白的表达。该组合还显著降低GFAP和p-nfκB p65在海马和皮层。 结论:联合干预可能会发挥更大的保护作用在SAMP8小鼠,这可能与事实相结合的干预可能会产生积极的影响作用的途径,与之相关的神经炎症,tau蛋白磷酸化和细胞凋亡标记可能。
关键词: 维生素D,白藜芦醇,阿尔茨海默病,淀粉样β,tau蛋白磷酸化,神经炎症、认知功能、内质网应激。
Current Alzheimer Research
Title:Vitamin D Combined with Resveratrol Prevents Cognitive Decline in SAMP8 Mice
Volume: 14 Issue: 8
关键词: 维生素D,白藜芦醇,阿尔茨海默病,淀粉样β,tau蛋白磷酸化,神经炎症、认知功能、内质网应激。
摘要: Background: Vitamin D (VD) and resveratrol (RSV) are two nutritional molecules that have reported neuroprotective effects, and findings from cellular models suggest that resveratrol could potentiate vitamin D’s effects. The senescence-accelerated mouse-prone 8 (SAMP8) is a useful model of Alzheimer's disease (AD)-related memory impairment.
Objective: We aimed to explore how the combination of vitamin D with resveratrol would affect memory impairments shown by SAMP8 mice, as well as the potential mechanisms. Method: SAMP8 mice and their control senescence-accelerated mouse resistant 1 (SAMR1) mice (10 weeks old) were divided into 5 groups, i.e. SAMR1 group, SAMP8 group, SAMP8 mice supplemented with VD group, SAMP8 mice supplemented with RSV group and SAMP8 mice supplemented with both VD and RSV group. At the end of the intervention, Morris water maze (MWM) test was used to assess cognitive function. Hippocampus and parietal cortex were dissected for further analysis. Results: The combination of VD and RSV significantly increased time spent in target quadrant and the number of crossing via MWM test. In hippocampus, the combined intervention significantly reduced soluble Aβ42 level and BACE1 protein expression. In cortex, the combined treatment significantly reduced phosphorylation of tau at serine404 and p-p53, as well as enhanced p-CREB protein expression. The combination also significantly reduced GFAP and p-NFκB p65 in both hippocampus and cortex. Conclusion: The combined intervention might exert greater neuroprotective effects in SAMP8 mice, this might be associated with the fact that the combined intervention could positively affect amyloidogenic pathways, neuroinflammation, tau phosphorylation and probably apoptosis markers.Export Options
About this article
Cite this article as:
Vitamin D Combined with Resveratrol Prevents Cognitive Decline in SAMP8 Mice, Current Alzheimer Research 2017; 14 (8) . https://dx.doi.org/10.2174/1567205014666170207093455
DOI https://dx.doi.org/10.2174/1567205014666170207093455 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Proteins of the Esterase Family: Patents for Some Proteins in Search of Metabolic Functions
Recent Patents on Biomarkers Nanomedicine and its Application in Treatment of Microglia-mediated Neuroinflammation
Current Medicinal Chemistry The Role of Atypical Antipsychotic Agents in the Treatment of Schizophrenia and Schizoaffective Disorders in the Elderly
Current Drug Safety Proprotein Convertase Subtilisin/kexin type 9 Inhibition in Cardiovascular Prevention
Current Pharmaceutical Design Oral Lipid Based Drug Delivery System (LBDDS): Formulation, Characterization and Application: A Review
Current Drug Delivery Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review
Current Molecular Medicine Molecular Hydrogen Application in Stroke: Bench to Bedside
Current Pharmaceutical Design Endothelial Dysfunction and Atherosclerosis: Focus on Novel Therapeutic Approaches
Recent Patents on Cardiovascular Drug Discovery A Study of Applications of Machine Learning Based Classification Methods for Virtual Screening of Lead Molecules
Combinatorial Chemistry & High Throughput Screening Ferric Cycle Activity and Alzheimer Disease
Current Neurovascular Research Daidzein and its Effects on Brain
Current Medicinal Chemistry Highly Significant Scaffolds to Design and Synthesis Cholinesterase Inhibitors as Anti-Alzheimer Agents
Mini-Reviews in Medicinal Chemistry Biological Evaluation of Azomethine-dihydroquinazolinone Conjugates as Cancer and Cholinesterase Inhibitors
Medicinal Chemistry Glycogen Synthase Kinase-3 in Neurodegeneration and Neuroprotection:Lessons from Lithium
Current Alzheimer Research Polydeoxyribonucleotide (PDRN): A Safe Approach to Induce Therapeutic Angiogenesis in Peripheral Artery Occlusive Disease and in Diabetic Foot Ulcers
Cardiovascular & Hematological Agents in Medicinal Chemistry Ximelagatran - A Promising New Drug in Thromboembolic Disorders
Current Pharmaceutical Design Mitochondrial Dysfunction and Alzheimers Disease
Current Alzheimer Research Editorial (Thematic Issue: Treating Major Age-Related Diseases in Older and Oldest Old Patients)
Current Pharmaceutical Design Do RAS Inhibitors Protect the Brain from Cerebral Ischemic Injury?
Current Hypertension Reviews Quantitative Gait Disturbances in Older Adults with Cognitive Impairments
Current Pharmaceutical Design